| Date Filed | Type | Description |
| 08/09/2023 |
4
| Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 999 shares
@ $2.67, valued at
$2.7k
|
|
| 05/10/2023 |
4
| Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Paid exercise price by delivering 969 shares
@ $4.14, valued at
$4k
|
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2022 |
4
| Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 364,000 options to buy
@ $3.77, valued at
$1.4M
|
|
| 10/12/2022 |
3
| Attar Eyal C. (Chief Medical Officer) has filed a Form 3 on Vor Biopharma Inc. |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Attar Eyal C. (SVP, Chief Medical Officer) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 33,000 shares
@ $0
Granted 75,000 shares
@ $0
Granted 143,000 options to buy
@ $6, valued at
$858k
|
|
| 03/26/2020 |
4
| Attar Eyal C. (SVP, Chief Medical Officer) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $35.5, valued at
$2M
|
|
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |